Clinical trials in Pozzilli – page 2

Groundbreaking research focusing on Multiple Sclerosis treatments, including studies of new therapies like frexalimab, remibrutinib, and ocrelizumab. Investigations aim to improve treatment efficacy and develop innovative drug delivery methods.

• Relapsing Multiple Sclerosis
• Progressive Multiple Sclerosis
• Radiologically Isolated Syndrome

Multiple ongoing trials evaluating both intravenous and subcutaneous administration methods for enhanced patient care.

Clinical research examining new therapeutic approaches for Parkinson's Disease, with particular attention to early-stage interventions and LRRK2-driven variants. Studies focus on novel compounds like NEU-411 and BIIB122.

• Early Parkinson's Disease
• Idiopathic Parkinson's Disease

Emphasis on safety evaluation and efficacy assessment of new therapeutic compounds.

Innovative studies targeting cardiovascular disease and related conditions, including trials of pelacarsen for lipoprotein management and inclisiran for preventing major cardiovascular events.

• Atherosclerotic Cardiovascular Disease
• Calcific Aortic Valve Stenosis

Focus on reducing cardiovascular events and improving outcomes in high-risk patients.

Research initiatives investigating treatments for sleep disorders and related neurological conditions, with studies evaluating TAK-861 for narcolepsy and new approaches for idiopathic hypersomnia.

• Narcolepsy with Cataplexy
• Idiopathic Hypersomnia

Trials focused on improving daily functioning and quality of life for patients.

Studies addressing Alzheimer's Disease psychosis and related conditions, with trials evaluating ACP-204 for symptom management and long-term safety assessments.

• Alzheimer's Disease Psychosis
• Nervous System Diseases

Research aimed at developing effective treatments for psychiatric symptoms in neurodegenerative conditions.